DG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0) (BioCAD00000021370)

all tissues

Metabolite Card

Formula: C45H72O5 (692.5379)
SMILES: [H][C@](CO)(COC(=O)CCCCCC\C=C/C\C=C/C\C=C/CCCCC)OC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCC

Synonyms [en]

DG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0); DAG(20:3/22:5); DG(20:3W6/22:5W6); Diacylglycerol(20:3W6/22:5W6); Diacylglycerol(42:8); 1-Homo-g-linolenoyl-2-osbondoyl-sn-glycerol

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021370). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/0:0), in particular, consists of one chain of homo-g-linolenic acid at the C-1 position and one chain of docosapentaenoic acid at the C-2 position. The homo-g-linolenic acid moiety is derived from fish oils, liver and kidney, while the docosapentaenoic acid moiety is derived from animal fats and brain. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

  • CAS Registry Number:
  • PubChem CID: 53478284
  • ChEBI:
  • HMDB: HMDB0007496
  • LipidMaps:
  • KEGG:
  • BioCyc:
  • NCBI MeSH:
  • Wikipedia:
Other DBLinks
  • PubChem: 53478284
  • HMDB: HMDB0007496
  • HMDB: HMDB07496
  • Metlin: METLIN_58994

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0068028 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
PathBank:SMP0035210 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))
PathBank:SMP0035214 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PathBank:SMP0035218 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0071637 Phosphatidylethanolamine Biosynthesis PE(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0076772 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0076776 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
PathBank:SMP0080782 Phosphatidylcholine Biosynthesis PC(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0092046 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0092050 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:1(15Z))
PathBank:SMP0068027 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0035209 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0035213 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:5(5Z,8Z,11Z,14Z,17Z))
PathBank:SMP0035217 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0076775 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
PathBank:SMP0082591 Phosphatidylethanolamine Biosynthesis PE(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0014703 Phosphatidylcholine Biosynthesis PC(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0015543 Phosphatidylethanolamine Biosynthesis PE(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0092049 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/24:0)
PathBank:SMP0068026 De Novo Triacylglycerol Biosynthesis TG(20:3(8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
View All Pathways